Xeris Biopharma Holdings, Inc. (FRA:2B30)
Germany · Delayed Price · Currency is EUR 6.12
+0.02 (0.33%)
At close: Nov 28, 2025
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of €993.39 million as of December 1, 2025. Its market cap has increased by 124.44% in one year.
Market Cap
993.39M
Enterprise Value
1.14B
Revenue
226.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.12
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from 256.47M to 993.39M, an increase of 287.33%. That is a compound annual growth rate of 38.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 1.03B | 110.47% |
| Dec 31, 2024 | 488.15M | 66.23% |
| Dec 29, 2023 | 293.66M | 73.53% |
| Dec 30, 2022 | 169.23M | -47.33% |
| Dec 31, 2021 | 321.29M | 25.28% |
| Oct 6, 2021 | 256.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |